Genes Diffusion, a leading global animal reproductive company, announced the acquisition of ReproQuest, a veterinary biotech company specializing in the development, manufacture and sale of artificial insemination products for swine.
For nearly a decade, ReproQuest has played an integral part in the artificial insemination industry by providing swine producers worldwide with products that deliver exceptional quality and performance at competitive prices.
With this acquisition, Genes Diffusion has established a newly formed subsidiary company, GenePro Inc. Dr. Kevin Rozeboom, former president and chief executive officer of ReproQuest, has been hired as the vice president of operations and business development for GenePro.
Genes Diffusion development manager Claude Grenier said, "This strategic acquisition will create greater efficiencies for the Genes Diffusion Group and its partners worldwide and accelerate delivery of key swine (insemination) products. In addition, GenePro is the ideal platform for the commercial launch of our upcoming line of innovative swine (artificial insemination) technologies".
Founded in 1948, Genes Diffusion specializes in the genetics and animal reproduction of bovine, porcine, equine and rabbit species. The Genes Diffusion Group's other U.S. subsidiary, Genes Diffusion USA, is active in boar stud management/consultation, quality assurance/quality control services as well as the marketing of dairy and beef genetics, bovine embryos and semen for the international industry.
